Terms: = Pancreatic cancer AND NTRK1, ENSG00000198400, 4914, P04629, TRK1, MTC, DKFZp781I14186, p140-TrkA, TRKA, TRK AND Treatment
40 results:
1. A clinical perspective on ectopic Cushing's syndrome.
Ragnarsson O; Juhlin CC; Torpy DJ; Falhammar H
Trends Endocrinol Metab; 2024 Apr; 35(4):347-360. PubMed ID: 38143211
[TBL] [Abstract] [Full Text] [Related]
2. Molecular basis and targeted therapy in thyroid cancer: Progress and opportunities.
Zhang L; Feng Q; Wang J; Tan Z; Li Q; Ge M
Biochim Biophys Acta Rev Cancer; 2023 Jul; 1878(4):188928. PubMed ID: 37257629
[TBL] [Abstract] [Full Text] [Related]
3. A Two-Step Diagnostic Approach for Ntrk Gene Fusion Detection in Biliary Tract and pancreatic Adenocarcinomas.
Demols A; Rocq L; Perez-Casanova L; Charry M; De Nève N; Ramadhan A; Van Campenhout C; De Clercq S; Maris C; Closset J; Lucidi V; Salmon I; D'Haene N
Oncologist; 2023 Jul; 28(7):e520-e525. PubMed ID: 36994874
[TBL] [Abstract] [Full Text] [Related]
4. treatment Patterns of Real-World Patients with trk Fusion cancer Treated by US Community Oncologists.
Klink AJ; Kavati A; Gassama A; Kozlek T; Gajra A; Antoine R
Target Oncol; 2022 Sep; 17(5):549-561. PubMed ID: 36089643
[TBL] [Abstract] [Full Text] [Related]
5. Targeting DNA damage repair pathways in pancreas cancer.
Crowley F; Park W; O'Reilly EM
Cancer Metastasis Rev; 2021 Sep; 40(3):891-908. PubMed ID: 34403012
[TBL] [Abstract] [Full Text] [Related]
6. Personalizing Medicine With Germline and Somatic Sequencing in Advanced pancreatic cancer: Current treatments and Novel Opportunities.
Lee MS; Pant S
Am Soc Clin Oncol Educ Book; 2021 Mar; 41():1-13. PubMed ID: 33929876
[TBL] [Abstract] [Full Text] [Related]
7. Early-Onset Pancreas cancer: Clinical Descriptors, Genomics, and Outcomes.
Varghese AM; Singh I; Singh R; Kunte S; Chou JF; Capanu M; Wong W; Lowery MA; Stadler ZK; Salo-Mullen E; Saadat LV; Wei AC; Reyngold M; Basturk O; Benayed R; Mandelker D; Iacobuzio-Donahue CA; Kelsen DP; Park W; Yu KH; O'Reilly EM
J Natl Cancer Inst; 2021 Sep; 113(9):1194-1202. PubMed ID: 33755158
[TBL] [Abstract] [Full Text] [Related]
8. New treatment Strategies for Metastatic pancreatic Ductal Adenocarcinoma.
Singh RR; O'Reilly EM
Drugs; 2020 May; 80(7):647-669. PubMed ID: 32306207
[TBL] [Abstract] [Full Text] [Related]
9. Larotrectinib in patients with trk fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials.
Hong DS; DuBois SG; Kummar S; Farago AF; Albert CM; Rohrberg KS; van Tilburg CM; Nagasubramanian R; Berlin JD; Federman N; Mascarenhas L; Geoerger B; Dowlati A; Pappo AS; Bielack S; Doz F; McDermott R; Patel JD; Schilder RJ; Tahara M; Pfister SM; Witt O; Ladanyi M; Rudzinski ER; Nanda S; Childs BH; Laetsch TW; Hyman DM; Drilon A
Lancet Oncol; 2020 Apr; 21(4):531-540. PubMed ID: 32105622
[TBL] [Abstract] [Full Text] [Related]
10. [Ntrk Fusions: A new way of treatment for gastro-intestinal tumor?].
Ouali K; Pellat A; Cohen R; Svrcek M; Penault-Llorca F; André T
Bull Cancer; 2020 Apr; 107(4):447-457. PubMed ID: 32067719
[TBL] [Abstract] [Full Text] [Related]
11. From state-of-the-art treatments to novel therapies for advanced-stage pancreatic cancer.
Nevala-Plagemann C; Hidalgo M; Garrido-Laguna I
Nat Rev Clin Oncol; 2020 Feb; 17(2):108-123. PubMed ID: 31705130
[TBL] [Abstract] [Full Text] [Related]
12. Tumour response to trk inhibition in a patient with pancreatic adenocarcinoma harbouring an Ntrk gene fusion.
O'Reilly EM; Hechtman JF
Ann Oncol; 2019 Nov; 30(Suppl_8):viii36-viii40. PubMed ID: 31605106
[TBL] [Abstract] [Full Text] [Related]
13. Harnessing the Immune System in pancreatic cancer.
Das S; Berlin J; Cardin D
Curr Treat Options Oncol; 2018 Aug; 19(10):48. PubMed ID: 30128712
[TBL] [Abstract] [Full Text] [Related]
14. A novel tropomyosin-related kinase A inhibitor, KK5101 to treat pancreatic cancer.
Fang Z; Han B; Jung KH; Lee JH; El-Damasy AK; Gadhe CG; Kim SJ; Yan HH; Park JH; Lee JE; Kang YW; Pae AN; Keum G; Hong SS
Cancer Lett; 2018 Jul; 426():25-36. PubMed ID: 29605512
[TBL] [Abstract] [Full Text] [Related]
15. Tropomyosin receptor kinase: a novel target in screened neuroendocrine tumors.
Aristizabal Prada ET; Heinzle V; Knösel T; Nölting S; Spöttl G; Maurer J; Spitzweg C; Angele M; Schmidt N; Beuschlein F; Stalla GK; Blaser R; Kuhn KA; Auernhammer CJ
Endocr Relat Cancer; 2018 May; 25(5):547-560. PubMed ID: 29563190
[TBL] [Abstract] [Full Text] [Related]
16. Sunitinib in the treatment of Thyroid cancer.
Ferrari SM; Centanni M; Virili C; Miccoli M; Ferrari P; Ruffilli I; Ragusa F; Antonelli A; Fallahi P
Curr Med Chem; 2019; 26(6):963-972. PubMed ID: 28990511
[TBL] [Abstract] [Full Text] [Related]
17. Recurrent Metastatic Medullary Thyroid Carcinoma: A Case of Sustained Response to Prolonged treatment with Somatostatin Analogues.
Cano JM; Galán R; López R
Thyroid; 2017 Nov; 27(11):1450-1455. PubMed ID: 28927353
[TBL] [Abstract] [Full Text] [Related]
18. The significance of trk receptors in pancreatic cancer.
Johnson MD; Stone B; Thibodeau BJ; Baschnagel AM; Galoforo S; Fortier LE; Ketelsen B; Ahmed S; Kelley Z; Hana A; Wilson TG; Robertson JM; Jury RP; Wilson GD
Tumour Biol; 2017 Feb; 39(2):1010428317692256. PubMed ID: 28218045
[TBL] [Abstract] [Full Text] [Related]
19. Blocking Nerve Growth Factor Signaling Reduces the Neural Invasion Potential of pancreatic cancer Cells.
Bapat AA; Munoz RM; Von Hoff DD; Han H
PLoS One; 2016; 11(10):e0165586. PubMed ID: 27792755
[TBL] [Abstract] [Full Text] [Related]
20. Cabozantinib: a MET, RET, and VEGFR2 tyrosine kinase inhibitor.
Grüllich C
Recent Results Cancer Res; 2014; 201():207-14. PubMed ID: 24756794
[TBL] [Abstract] [Full Text] [Related]
[Next]
